{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:58:25Z","timestamp":1783994305686,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771530"],"award-info":[{"award-number":["81771530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801406"],"award-info":[{"award-number":["81801406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Municipal Administration of Hospitals\u2019 Youth Programme","award":["QML20181402"],"award-info":[{"award-number":["QML20181402"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.micpath.2019.103562","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:41:20Z","timestamp":1559270480000},"page":"103562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Therapeutic effectiveness of type I interferon in vulvovaginal candidiasis"],"prefix":"10.1016","volume":"134","author":[{"given":"Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2019.103562_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12905-018-0607-z","article-title":"Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern","volume":"18","author":"Bitew","year":"2018","journal-title":"BMC Women's Health"},{"key":"10.1016\/j.micpath.2019.103562_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12866-018-1316-3","article-title":"Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2019.103562_bib3","article-title":"Candidiasis (vulvovaginal), BMJ","volume":"2015","author":"Martin Lopez","year":"2015","journal-title":"Clin. Evid."},{"key":"10.1016\/j.micpath.2019.103562_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.fgb.2012.01.008","article-title":"Non-lytic expulsion\/exocytosis of Candida albicans from macrophages","volume":"49","author":"Bain","year":"2012","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.micpath.2019.103562_bib5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2217\/FMB.15.47","article-title":"Medically important fungi respond to azole drugs: an update","volume":"10","author":"Zavrel","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2019.103562_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/17460441.2013.807245","article-title":"Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs","volume":"8","author":"Pierce","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.micpath.2019.103562_bib7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1233321","article-title":"Interferon-\u03b5 protects the female reproductive tract from viral and bacterial infection","volume":"339","author":"Fung","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.micpath.2019.103562_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00018-010-0605-2","article-title":"The STING pathway and regulation of innate immune signaling in response to DNA pathogens","volume":"68","author":"Ishikawa","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.micpath.2019.103562_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","article-title":"Interferon alpha: the key trigger of type 1 diabetes","volume":"94","author":"Lombardi","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.micpath.2019.103562_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2019.103562_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pep.2013.05.002","article-title":"Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon \u03b11 fusion protein expressed in Pichia pastoris","volume":"90","author":"Tian","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.micpath.2019.103562_bib12","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1128\/IAI.73.11.7765-7767.2005","article-title":"Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis","volume":"73","author":"Barousse","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2019.103562_bib13","article-title":"Molecular and biological characterization of a prepared recombinant human interferon alpha 2b isoform","author":"Shaaban","year":"2018","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.micpath.2019.103562_bib14","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","article-title":"The roles of type I interferon in bacterial infection","volume":"19","author":"Boxx","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2019.103562_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fmicb.2017.00697","article-title":"Recombinant human IFN\u03b1-2b response promotes vaginal epithelial cells defense against Candida albicans","volume":"20","author":"Li","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2019.103562_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/21505594.2015.1012981","article-title":"Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface","volume":"6","author":"Moyes","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2019.103562_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0022034511399285","article-title":"Epithelial cell innate response to Candida albicans","volume":"23","author":"Naglik","year":"2011","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.micpath.2019.103562_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13568-016-0281-1","article-title":"Baofukang suppository promotes the repair of vaginal epithelial cells in response to Candida albicans","volume":"6","author":"Li","year":"2016","journal-title":"Amb. Express"},{"key":"10.1016\/j.micpath.2019.103562_bib19","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/nprot.2006.474","article-title":"Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia","volume":"1","author":"Schaller","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.micpath.2019.103562_bib20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/JVI.01715-10","article-title":"Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection","volume":"85","author":"Conrady","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2019.103562_bib21","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2011"},{"key":"10.1016\/j.micpath.2019.103562_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/OLQ.0000000000000039","article-title":"Image-based noninvasive evaluation of colorectal mucosal injury in sheep after topical application of microbicides","volume":"40","author":"Vincent","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.micpath.2019.103562_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-5223(19)37950-4","article-title":"Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man","volume":"79","author":"Flameng","year":"1980","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.micpath.2019.103562_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/jid.2010.420","article-title":"Epithelial regulation of mesenchymal tissue behavior","volume":"131","author":"Gallant-Behm","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.micpath.2019.103562_bib25","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/eji.201141490","article-title":"Mancuso Recognition of yeast nucleic acids triggers a host-protective type I interferon response","volume":"41","author":"Biondo","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2019.103562_bib26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jmb.2013.12.003","article-title":"Innate antiviral immune signaling, viral evasion and modulation by HIV-1","volume":"426","author":"Rustagi","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2019.103562_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1251\/bpo118","article-title":"Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality","volume":"8","author":"Austin","year":"2006","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.micpath.2019.103562_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fcimb.2018.00312","article-title":"Abortigenic but not neurotropic equine herpes virus 1 modulates the interferon antiviral defense","volume":"8","author":"Poelaert","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2019.103562_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2013.05.218","article-title":"Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans","volume":"56","author":"Luo","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2019.103562_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.micres.2013.02.008","article-title":"Disruption of the intestinal mucosal barrier in Candida albicans infections","volume":"168","author":"Yan","year":"2013","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.micpath.2019.103562_bib31","doi-asserted-by":"crossref","first-page":"E2456","DOI":"10.3390\/ijms19082456","article-title":"Toll-like receptor agonists modulate wound regeneration in airway epithelial cells","volume":"19","author":"Lewandowska-Polak","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2019.103562_bib32","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.3892\/or.2015.4294","article-title":"Autocrine interferon-\u03b3 may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor \u03b2 subtype","volume":"34","author":"Niu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.micpath.2019.103562_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/eri.11.152","article-title":"Candida albicans dimorphism as a therapeutic target","volume":"10","author":"Jacobsen","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2019.103562_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signaling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2019.103562_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2741\/4281","article-title":"Role of IFN-gamma in immune responses to Candida albicans infections","volume":"19","author":"Gozalbo","year":"2014","journal-title":"Front. Biosci."},{"key":"10.1016\/j.micpath.2019.103562_bib36","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/ncomms2343","article-title":"Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans","volume":"4","author":"Smeekens","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2019.103562_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/2141-9248.133470","article-title":"Factors associated with symptomatic vulvovaginal candidiasis: a study among women attending a primary healthcare clinic in kwazulu-natal, South Africa","volume":"4","author":"Apalata","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.micpath.2019.103562_bib38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2019.103562_bib39","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3390\/ijms16022574","article-title":"IgG and IgA with potential microbial-binding activity are expressed by normal human skin epidermal cells","volume":"16","author":"Jiang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2019.103562_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.chom.2011.04.007","article-title":"A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus","volume":"9","author":"Ramirez-Ortiz","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2019.103562_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/odi.12527","article-title":"Desmosomes in disease: a guide for clinicians","volume":"23","author":"Celentano","year":"2017","journal-title":"Oral Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240101930186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240101930186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:21:27Z","timestamp":1760109687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240101930186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":41,"alternative-id":["S088240101930186X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2019.103562","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effectiveness of type I interferon in vulvovaginal candidiasis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2019.103562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103562"}}